4DMT Completes Enrollment of Phase 2 PRISM Clinical Trial for Intravitreal 4D-150 in Patients with Wet AMD and Reports Interim Safety and Tolerability Data
Completed target enrollment of 50 patients in the randomized Phase 2 Dose Expansion stage of…
Completed target enrollment of 50 patients in the randomized Phase 2 Dose Expansion stage of…
– The funding will support NB001 Parkin gene replacement therapy IND-enabling studies– Initial indication in…
LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today…
Integrating Syntellis’ Axiom™ Higher Education Suite will accelerate informed decision-making and enhance financial planning processes…
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
CHICAGO, IL, Jul 18, 2023 – (ACN Newswire) – Aircraft Engine Lease Finance, Inc. (“AELF”)…
WICHITA, Kan.–(BUSINESS WIRE)–Textron Aviation announced today significant enhancements to its iconic Cessna high-wing piston aircraft…
TAMPA, Fla.–(BUSINESS WIRE)–Deepwatch, the leader in advanced managed detection and response (MDR) security, announced today…
Strategic Partnership Helps Insurers Deliver Better Outcomes for Injured Workers SANTA CLARA, Calif. & SYDNEY–(BUSINESS…
Latest milestone achievement underscores the company’s unparalleled commitment to continuous innovation to enable enterprises to…
MONTREAL, July 17, 2023 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:…
Following the retirement of CEO Bob Watson, Rajib Roy and Kent T. Kelley will guide…
Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer Villepinte, 17 July 2023: Guerbet…
FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease Beyfortus™ is the first monoclonal…
Wider deployment of 5G service, increased capacity on fiber and more bandwidth are among recent…